SCHEMBL7579145

SCHEMBL7579145

O=S(=O)(Nc1ccccc1)c1c(F)cccc1F

nearest known ligand 0.83

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.83
KEAP1 Q14145 2/20 0.55
IL1RN P18510 1/20 0.55
ERAP1 Q9NZ08 1/20 0.55
KMT2A Q03164 2/20 0.52
ALDH1A1 P00352 2/20 0.52
MEN1 O00255 1/20 0.52
PTK2B Q14289 1/20 0.49
SLC40A1 Q9NP59 2/20 0.47
PGR P06401 1/20 0.47
POLB P06746 1/20 0.47
CA1 P00915 4/20 0.47
CA2 P00918 4/20 0.47
CA12 O43570 1/20 0.47
CA9 Q16790 1/20 0.47
HTR6 P50406 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27335781 0.88 PKM (0.67) PKMKEAP1IL1RNERAP1KMT2A
SCHEMBL7572618 0.86 PKM (0.70) PKMKMT2AALDH1A1MEN1SLC40A1
SCHEMBL96565 0.83 PKM (0.66) PKMKEAP1IL1RNERAP1KMT2A
SCHEMBL7569548 0.83 PKM (0.66) PKMKMT2AALDH1A1MEN1SLC40A1
SCHEMBL6073362 0.82 CA1 (0.62) PKMKEAP1IL1RNERAP1KMT2A
SCHEMBL7595736 0.82 SLC40A1 (0.61) PKMSLC40A1CA1CA2
SCHEMBL28270280 0.80 HTR6 (0.61) PKMKMT2AMEN1SLC40A1POLB
SCHEMBL29530798 0.80 HTR6 (0.61) PKMKMT2AMEN1SLC40A1POLB
SCHEMBL22145982 0.80 SLC40A1 (0.59) PKMALDH1A1SLC40A1POLBCA1
SCHEMBL7163015 0.80 ALDH1A1 (0.68) PKMKEAP1IL1RNERAP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3246028-A1 QUINOLINE COMPOUNDS FOR INCREASING INSULINE RELEASE Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2017-11-22 EP disclosed
EP-1239852-A2 BISSULFONAMIDE DERIVATIVES AS ENZYME INHIBITORS Arrow Therapeutics Limited (GB) 2002-09-18 EP disclosed
WO-2001028537-A2 BISSULFONAMIDE DERIVATIVES AS ENZYME INHIBITORS ARROW THERAPEUTICS LIMITED (GB) 2001-04-26 WO disclosed